• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Recruitment to the Proteasome Is Necessary but Not Sufficient for Chemically Induced, Ubiquitin-Independent Degradation of Native Proteins.蛋白酶体的募集对于化学诱导的、不依赖泛素的天然蛋白质降解是必要的,但并不充分。
ACS Chem Biol. 2024 Nov 15;19(11):2323-2335. doi: 10.1021/acschembio.4c00422. Epub 2024 Oct 22.
2
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
3
In-Cell Approach to Evaluate E3 Ligases for Use in Targeted Protein Degradation.用于评估靶向蛋白质降解中E3连接酶的细胞内方法。
J Am Chem Soc. 2025 Jun 25;147(25):21560-21574. doi: 10.1021/jacs.5c02741. Epub 2025 Jun 10.
4
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.改善消费者安全有效用药的干预措施:系统评价概述
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD007768. doi: 10.1002/14651858.CD007768.pub3.
5
Cullin 3-mediated ubiquitination restricts enterovirus D68 replication and is counteracted by viral protease 3C.Cullin 3介导的泛素化作用限制肠道病毒D68的复制,并被病毒蛋白酶3C所抵消。
J Virol. 2025 Jun 17;99(6):e0035425. doi: 10.1128/jvi.00354-25. Epub 2025 May 21.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
PROteolysis TArgeting Chimera (PROTAC) Estrogen Receptor Degraders for Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.用于治疗雌激素受体阳性晚期乳腺癌的蛋白酶靶向嵌合体(PROTAC)雌激素受体降解剂
Target Oncol. 2025 May;20(3):431-444. doi: 10.1007/s11523-025-01137-5. Epub 2025 May 6.
8
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.卡马西平与苯妥英钠单药治疗癫痫:个体参与者数据回顾
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD001911. doi: 10.1002/14651858.CD001911.pub3.
9
Umbelliferone attenuates diabetic sarcopenia by modulating mitochondrial quality and the ubiquitin-proteasome system.伞形花内酯通过调节线粒体质量和泛素-蛋白酶体系统减轻糖尿病性肌肉减少症。
Phytomedicine. 2025 Aug;144:156930. doi: 10.1016/j.phymed.2025.156930. Epub 2025 May 31.
10
The vaccinia virus protein, C16, promotes the ubiquitylation and relocalization of the antiviral E3 ubiquitin-ligase, TRIM25.痘苗病毒蛋白C16可促进抗病毒E3泛素连接酶TRIM25的泛素化及重新定位。
J Virol. 2025 Jul 28:e0089825. doi: 10.1128/jvi.00898-25.

引用本文的文献

1
Assessing the Suitability of Deubiquitylases As Substrates For Targeted Protein Degradation.评估去泛素化酶作为靶向蛋白质降解底物的适用性。
bioRxiv. 2025 Jun 14:2025.06.13.659525. doi: 10.1101/2025.06.13.659525.
2
Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease.不依赖泛素的蛋白酶体降解机制及其在年龄相关性神经退行性疾病中的作用。
Front Cell Dev Biol. 2025 Feb 7;12:1531797. doi: 10.3389/fcell.2024.1531797. eCollection 2024.
3
Small molecule targeted protein degradation the UPS: venturing beyond E3 substrate receptors.小分子靶向蛋白质降解与泛素-蛋白酶体系统:超越E3底物受体的探索
RSC Med Chem. 2025 Feb 12. doi: 10.1039/d4md00718b.
4
Exploration of degrons and their ability to mediate targeted protein degradation.降解结构域及其介导靶向蛋白质降解能力的探索。
RSC Med Chem. 2025 Jan 1. doi: 10.1039/d4md00787e.
5
Ubiquitin-Independent Degradation: An Emerging PROTAC Approach?不依赖泛素的降解:一种新兴的PROTAC方法?
Bioessays. 2025 Feb;47(2):e202400161. doi: 10.1002/bies.202400161. Epub 2024 Nov 26.

本文引用的文献

1
Catalytic Protein Inhibitors.催化蛋白抑制剂。
Angew Chem Int Ed Engl. 2024 Mar 11;63(11):e202316726. doi: 10.1002/anie.202316726. Epub 2024 Jan 12.
2
Ubiquitin-independent proteasomal degradation driven by C-degron pathways.依赖泛素的蛋白酶体降解途径驱动的 C 端降解序列。
Mol Cell. 2023 Jun 1;83(11):1921-1935.e7. doi: 10.1016/j.molcel.2023.04.023. Epub 2023 May 17.
3
PROTAC Linkerology Leads to an Optimized Bivalent Chemical Degrader of Polycomb Repressive Complex 2 (PRC2) Components.靶向蛋白降解嵌合体连接体化学优化导致多梳抑制复合物 2(PRC2)组件的双价化学降解剂。
ACS Chem Biol. 2023 Mar 17;18(3):494-507. doi: 10.1021/acschembio.2c00804. Epub 2023 Mar 6.
4
Targeted degradation via direct 26S proteasome recruitment.通过直接 26S 蛋白酶体招募进行靶向降解。
Nat Chem Biol. 2023 Jan;19(1):55-63. doi: 10.1038/s41589-022-01218-w. Epub 2022 Dec 28.
5
Functional E3 ligase hotspots and resistance mechanisms to small-molecule degraders.功能 E3 连接酶热点和小分子降解剂的耐药机制。
Nat Chem Biol. 2023 Mar;19(3):323-333. doi: 10.1038/s41589-022-01177-2. Epub 2022 Nov 3.
6
Current strategies for the design of PROTAC linkers: a critical review.PROTAC连接子设计的当前策略:批判性综述。
Explor Target Antitumor Ther. 2020;1(5):273-312. doi: 10.37349/etat.2020.00018. Epub 2020 Oct 30.
7
Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation.直接合成生物学加速PROTAC的合成以及对连接子对渗透性和降解影响的评估。
ACS Med Chem Lett. 2022 Jun 20;13(7):1182-1190. doi: 10.1021/acsmedchemlett.2c00124. eCollection 2022 Jul 14.
8
Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer.CDK9 PROTAC 化合物在 HER2 阳性乳腺癌中的抗肿瘤活性。
Int J Mol Sci. 2022 May 13;23(10):5476. doi: 10.3390/ijms23105476.
9
Synthesis and Screening of a DNA-Encoded Library of Non-Peptidic Macrocycles.DNA 编码大环非肽库的合成与筛选。
Angew Chem Int Ed Engl. 2022 Apr 25;61(18):e202116999. doi: 10.1002/anie.202116999. Epub 2022 Mar 2.
10
Molecular Glues for Targeted Protein Degradation: From Serendipity to Rational Discovery.分子胶靶向蛋白降解剂:从偶然发现到合理发现。
J Med Chem. 2021 Aug 12;64(15):10606-10620. doi: 10.1021/acs.jmedchem.1c00895. Epub 2021 Jul 28.

蛋白酶体的募集对于化学诱导的、不依赖泛素的天然蛋白质降解是必要的,但并不充分。

Recruitment to the Proteasome Is Necessary but Not Sufficient for Chemically Induced, Ubiquitin-Independent Degradation of Native Proteins.

作者信息

Balzarini Madeline, Tong Joel, Gui Weijun, Jayalath Isuru M, Schell Bin-Bin, Kodadek Thomas

机构信息

Skaggs Graduate School of Chemical and Biological Sciences , 120 Scripps Way, Jupiter, Florida 33458, United States.

Department of Chemistry, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, 120 Scripps Way, Jupiter, Florida 33458, United States.

出版信息

ACS Chem Biol. 2024 Nov 15;19(11):2323-2335. doi: 10.1021/acschembio.4c00422. Epub 2024 Oct 22.

DOI:10.1021/acschembio.4c00422
PMID:39439063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11707830/
Abstract

Targeted protein degradation (TPD) is a promising strategy for drug development. Most degraders function by forcing the association of the target protein (TP) with an E3 Ubiquitin (Ub) ligase, which, in favorable cases, results in the polyubiquitylation of the TP and its subsequent degradation by the 26S proteasome. An alternative strategy would be to create chemical dimerizers that bypass the requirement for polyubiquitylation by recruiting the target protein directly to the proteasome. Direct-to-proteasome degraders (DPDs) may exhibit different characteristics than ubiquitin-dependent degraders, but few studies of this type of TPD have been published, largely due to the dearth of suitable proteasome ligands. To facilitate studies of DPDs, we report here a mammalian cell line in which the HaloTag protein is fused to the proteasome via Rpn13, one of the ubiquitin receptors. In these cells, a chloroalkane serves as a covalent proteasome ligand surrogate. We show that chimeric molecules comprised of a chloroalkane linked to a ligand for the BET family of proteins or the Cdk2/7/9 family of kinases result in ubiquitin-independent degradation of some of these target proteins. We use this system, the first that allows facile degradation of native proteins in a ubiquitin-independent fashion, to probe two issues: the effect of varying the length of the linker connecting the chloroalkane and the target ligand and the selectivity of degradation within the protein families engaged by the target ligand.

摘要

靶向蛋白质降解(TPD)是一种很有前景的药物开发策略。大多数降解剂的作用方式是促使靶蛋白(TP)与E3泛素(Ub)连接酶结合,在有利的情况下,这会导致TP的多聚泛素化及其随后被26S蛋白酶体降解。另一种策略是创建化学二聚体,通过将靶蛋白直接招募到蛋白酶体来绕过对多聚泛素化的需求。直接作用于蛋白酶体的降解剂(DPD)可能表现出与泛素依赖性降解剂不同的特性,但关于这类TPD的研究很少发表,主要是因为缺乏合适的蛋白酶体配体。为了促进对DPD的研究,我们在此报告一种哺乳动物细胞系,其中HaloTag蛋白通过泛素受体之一Rpn13与蛋白酶体融合。在这些细胞中,氯代烷烃作为共价蛋白酶体配体替代物。我们表明,由与BET家族蛋白或Cdk2/7/9家族激酶的配体连接的氯代烷烃组成的嵌合分子会导致其中一些靶蛋白的泛素非依赖性降解。我们使用这个系统——第一个允许以泛素非依赖性方式轻松降解天然蛋白质的系统——来探究两个问题:连接氯代烷烃和靶配体的接头长度变化的影响以及靶配体所涉及的蛋白质家族内降解的选择性。